COMMUNIQUÉS West-GlobeNewswire

ThromboGenics Long-time Non-executive Director Thomas Clay Appointed Chairman of the Board of Directors

15/06/2017 - 17:40

Leuven, Belgium, 15 June 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announces that the Board has appointed long-time non-executive [...]

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units

15/06/2017 - 15:09

Lars Lund-Roland, member of the Board of Targovax ASA, has on 15 June 2017 subscribed for 16,394 shares in Targovax ASA at a price of NOK 0.10 per share in connection with settlement of vested restricted stock units (" [...]

RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA(TM)) for H. pylori Infection

15/06/2017 - 14:00

Subject to a successful outcome and any additional regulatory feedback, the confirmatory Phase III study (ERADICATE Hp 2) is expected to complete the package required for a potential U.S. NDA for RHB-105, newly branded [...]

Summit Therapeutics to Participate in JMP Securities Life Sciences Conference

15/06/2017 - 13:00

Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN JMP SECURITIES LIFE SCIENCES CONFERENCE Oxford, UK, 15 June 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]

uniQure Publishes Data Further Demonstrating Favorable Immunogenicity Profile and Broad Utilization of AAV5-Based Gene Therapies

15/06/2017 - 13:00

-- Study published in Molecular Therapy provides proof of concept of successful cross-administration of AAV5- and AAV1-based gene therapies -- LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 15, 2017 (GLOBE [...]

NCSBN CEO Benton Receives Great Cross of Spanish Nursing from the Spanish General Council of Nursing

15/06/2017 - 12:00

CHICAGO, June 15, 2017 (GLOBE NEWSWIRE) -- NCSBN CEO David Benton, RGN, PhD, FFNF, FRCN, FAAN, received the Great Cross of Spanish Nursing in the Gold Category from the Spanish General Council of Nursing in Barcelona, [...]

Pöyry and Betulium sign co-operation agreement to unlock full value chain benefits for clients in bio-based businesses

15/06/2017 - 11:00

Pöyry and Betulium have signed a Letter of Intent (LOI) for co-operation that will enable both companies to serve their clients better in bio-based businesses. Pöyry and Betulium share common objectives in bioindustry: [...]

Zealand increases its share capital as a consequence of exercise of employee warrants

15/06/2017 - 10:11

Copenhagen, June 15, 2017 - Zealand Pharma ("Zealand") has increased its share capital by a nominal amount of DKK 8,537 divided into 8,537 new shares with a nominal value of DKK 1 each. The increase is a consequence of [...]

ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today

15/06/2017 - 07:17

Zutphen, The Netherlands, 15 June 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a third Packed Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]

Novartis' Cosentyx shows sustained improvements in signs and symptoms for both AS and PsA in up to 80% of patients at 3 years

15/06/2017 - 07:15

Cosentyx ® is the first and only IL-17A inhibitor to show sustained improvements in signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA)[1],[2] Additional data show rapid and sustained pain [...]

TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis

15/06/2017 - 07:00

PRESS RELEASE TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis - Joins the Crohn's and Colitis Foundation's President's Corporate Circle - Signs [...]

INNATE PHARMA : Dose-escalation data show favorable safety profile and promising clinical activity for IPH4102

15/06/2017 - 07:00

DOSE-ESCALATION DATA SHOW favorable SAFETY PROFILE AND PROMISING CLINICAL ACTIVITY FOR IPH4102 Oral presentation on the dose-escalation part of a Phase I trial at the International Conference on Malignant Lymphoma (ICML [...]

INNATE PHARMA : Résultats d'escalade de dose d'IPH4102 : Profil de tolérance et activité clinique prometteurs

15/06/2017 - 07:00

rÉsultats d'escalade de dose d'IPH4102 : profil de tolÉrance et activitÉ clinique prometteurs La partie en escalade de dose de l'essai de Phase I a fait l'objet d'une présentation orale lors de l'ICML [1] à Lugano ; [...]

Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan

15/06/2017 - 07:00

Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan Paris, France - June 15, 2017 - Sanofi announced today the launch of "Action 2017", a worldwide stock purchase plan reserved for its employees. In [...]

Sanofi lance « Action 2017 », un plan mondial d'actionnariat salarié

15/06/2017 - 07:00

Sanofi lance « Action 2017 », un plan mondial d'actionnariat salarié Paris, France - Le 15 juin 2017 - Sanofi annonce aujourd'hui le lancement d' « Action 2017 », un plan mondial d'actionnariat salarié. En procédant à [...]

Basilea announces license agreement with Pfizer for antifungal Cresemba® (isavuconazole) for Europe, Russia, Turkey and Israel

14/06/2017 - 19:15

Press release (PDF) This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]

SPINEWAY enregistre une nouvelle commande d'1 M$ aux USA

14/06/2017 - 18:15

Communiqué de presse Ecully, le 14 juin 2017 SPINEWAY enregistre une nouvelle commande d'1 M$ aux USA Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la colonne [...]

SPINEWAY records a new $1M order in the USA

14/06/2017 - 18:15

Press release Ecully, 14 June 2017 SPINEWAY records a new $1M order in the USA Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has obtained a new order via [...]

Guerbet investit dans le fonds de Truffle Capital dédié aux dispositifs médicaux et biotechnologies

14/06/2017 - 18:04

Villepinte, le 14 juin 2017 - 18:00 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale annonce avoir signé une prise de participation d'un montant de quinze [...]